Biomerica, Inc. (BMRA)

Biomerica Income Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Revenue	5.31	5.42	5.34	18.87	7.2
Revenue Growth (YoY)	-1.92%	1.42%	-71.71%	162.13%	7.56%
Cost of Revenue	4.81	4.8	4.89	15.89	6.83
Gross Profit	0.5	0.61	0.45	2.98	0.37
Selling, General & Admin	4.61	5.49	6.09	5.7	5.67
Research & Development	1.02	1.49	1.58	1.81	2.19
Operating Expenses	5.64	6.98	7.67	7.51	7.87
Operating Income	-5.14	-6.37	-7.22	-4.53	-7.5
Interest Expense	-	-	-	-	-0
Interest & Investment Income	0.17	0.43	0.13	0.03	0.07
Other Non Operating Income (Expenses)	-	-	0	-	-
Pretax Income	-4.97	-5.94	-7.09	-4.51	-7.43
Income Tax Expense	0	0.04	0.05	0.02	0.01
Net Income	-4.97	-5.98	-7.14	-4.53	-7.45
Net Income to Common	-4.97	-5.98	-7.14	-4.53	-7.45
Shares Outstanding (Basic)	2	2	2	2	1
Shares Outstanding (Diluted)	2	2	2	2	1
Shares Change (YoY)	9.22%	18.87%	11.69%	6.24%	17.34%
EPS (Basic)	-2.16	-2.84	-4.04	-2.86	-4.99
EPS (Diluted)	-2.16	-2.84	-4.04	-2.88	-4.99
Free Cash Flow	-3.84	-5.41	-5.54	-0.54	-5.39
Free Cash Flow Per Share	-1.67	-2.57	-3.13	-0.34	-3.61
Gross Margin	9.38%	11.28%	8.35%	15.78%	5.09%
Operating Margin	-96.72%	-117.58%	-135.29%	-24.03%	-104.18%
Profit Margin	-93.64%	-110.40%	-133.73%	-24.01%	-103.43%
Free Cash Flow Margin	-72.32%	-99.94%	-103.73%	-2.84%	-74.84%
EBITDA	-5.05	-6.29	-7.14	-4.2	-7.36
EBITDA Margin	-95.09%	-116.08%	-133.71%	-22.23%	-102.26%
D&A For EBITDA	0.09	0.08	0.08	0.34	0.14
EBIT	-5.14	-6.37	-7.22	-4.53	-7.5
EBIT Margin	-96.72%	-117.58%	-135.29%	-24.03%	-104.18%
Advertising Expenses	0.04	0.1	0.16	0.08	0.01

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q